Portfolio of Bridgewater Associates
Bridgewater Associates was founded by Ray Dalio, who handed over leadership in 2022; the hedge fund follows a macroeconomic approach with a broadly diversified portfolio.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 13, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2025. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 27.4B USD
- Positions
- 1,040
- Share of the ten largest
- 36.3%
The ten largest positions Q4 2025
- SPDR S&P 500 ETF TR 11.1%▲ +73.7%
- Ishares TR 10.5%▲ +3.4%
- Nvidia 2.6%▲ +54.0%
- Lam Research 1.9%▼ −12.2%
- Salesforce 1.9%▼ −3.7%
- Alphabet Inc. (Class A) 1.8%▼ −40.1%
- Microsoft 1.7%▼ −10.3%
- Amazon 1.6%▲ +73.2%
- Adobe Inc. 1.6%▲ +1.0%
- GE Vernova 1.6%▲ +2.3%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q4 2025
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| LRCX Lam Research | 1.9% | 3,041,661 | 520.7M USD | −12.2% reduced | Q1 2022 16 quarters |
| CRM Salesforce | 1.9% | 1,932,066 | 511.8M USD | −3.7% reduced | Q1 2023 12 quarters |
| GOOGL Alphabet Inc. (Class A) | 1.8% | 1,590,826 | 497.9M USD | −40.1% reduced | Q4 2020 21 quarters |
| MSFT Microsoft | 1.7% | 984,091 | 475.9M USD | −10.3% reduced | Q4 2020 21 quarters |
| AMD Advanced Micro Devices | 1.3% | 1,656,527 | 354.8M USD | −7.7% reduced | Q1 2024 8 quarters |
| JNJ Johnson & Johnson | 1.0% | 1,313,958 | 271.9M USD | −23.4% reduced | Q3 2020 22 quarters |
| WDAY Workday, Inc. | 0.8% | 965,117 | 207.3M USD | −7.2% reduced | Q4 2019 25 quarters |
| NOW ServiceNow | 0.7% | 1,338,885 | 205.1M USD | −11.3% reducedafter 5:1 stock split | Q4 2024 5 quarters |
| SE Sea Limited (ADR) | 0.7% | 1,533,269 | 195.6M USD | −4.5% reduced | Q2 2022 15 quarters |
| MO Altria | 0.7% | 3,276,751 | 188.9M USD | −11.3% reduced | Q3 2021 18 quarters |
| V Visa Inc. | 0.7% | 536,497 | 188.2M USD | −20.6% reduced | Q1 2021 20 quarters |
| EXPE Expedia Group | 0.6% | 622,783 | 176.4M USD | −14.9% reduced | Q1 2022 16 quarters |
| British Amern Tob PLC | 0.6% | 2,952,078 | 167.1M USD | −21.1% reduced | Q3 2024 6 quarters |
| HCA HCA Healthcare | 0.6% | 329,307 | 153.7M USD | −3.3% reduced | Q1 2020 24 quarters |
| META Meta Platforms | 0.5% | 223,701 | 147.7M USD | −46.3% reduced | Q4 2020 21 quarters |
| WFC Wells Fargo | 0.4% | 1,141,540 | 106.4M USD | −55.0% reduced | Q4 2023 9 quarters |
| UBER Uber | 0.4% | 1,289,061 | 105.3M USD | −64.2% reduced | Q1 2022 16 quarters |
| CMCSA Comcast | 0.4% | 3,510,012 | 104.9M USD | −48.8% reduced | Q1 2021 20 quarters |
| KLAC KLA Corporation | 0.3% | 78,367 | 95.2M USD | −30.5% reduced | Q2 2023 11 quarters |
| CI Cigna | 0.3% | 344,452 | 94.8M USD | −42.9% reduced | Q2 2021 19 quarters |
| Manulife Finl Corp | 0.3% | 2,558,071 | 93.0M USD | −14.5% reduced | Q2 2024 7 quarters |
| ASML ASML Holding (ADR) | 0.3% | 86,089 | 92.1M USD | −4.6% reduced | Q3 2024 6 quarters |
| C Citigroup | 0.3% | 716,325 | 83.6M USD | −43.2% reduced | Q4 2022 13 quarters |
| CVS CVS Health | 0.3% | 1,037,352 | 82.3M USD | −13.1% reduced | Q1 2020 24 quarters |
| MET MetLife | 0.3% | 1,017,093 | 80.3M USD | −38.7% reduced | Q1 2022 16 quarters |
| NXPI NXP Semiconductors | 0.3% | 362,586 | 78.7M USD | −30.8% reduced | Q2 2022 15 quarters |
| AAPL Apple Inc. | 0.3% | 289,471 | 78.7M USD | −16.0% reduced | Q4 2023 9 quarters |
| Vale S A | 0.3% | 6,024,497 | 78.5M USD | −17.9% reduced | Q1 2024 8 quarters |
| GPN Global Payments | 0.3% | 958,080 | 74.2M USD | −23.2% reduced | Q3 2021 18 quarters |
| Shell PLC | 0.3% | 1,003,577 | 73.7M USD | −10.3% reduced | Q3 2024 6 quarters |
| HIG Hartford (The) | 0.3% | 509,996 | 70.3M USD | −24.2% reduced | Q4 2022 13 quarters |
| GRAB Grab Holdings | 0.2% | 11,534,093 | 57.6M USD | −24.0% reduced | Q4 2024 5 quarters |
| Ryanair Holdings PLC | 0.2% | 795,029 | 57.4M USD | −18.9% reduced | Q1 2025 4 quarters |
| REGN Regeneron Pharmaceuticals | 0.2% | 72,745 | 56.1M USD | −69.1% reduced | Q2 2021 19 quarters |
| VST Vistra Corp. | 0.2% | 309,849 | 50.0M USD | −8.4% reduced | Q2 2023 11 quarters |
| EME EMCOR Group | 0.2% | 81,422 | 49.8M USD | −19.9% reduced | Q2 2024 7 quarters |
| UHS Universal Health Services | 0.2% | 220,012 | 48.0M USD | −24.1% reduced | Q1 2020 24 quarters |
| CRDO Credo Technology Group | 0.2% | 321,111 | 46.2M USD | −9.0% reduced | Q3 2025 2 quarters |
| CAH Cardinal Health | 0.2% | 216,669 | 44.5M USD | −20.4% reduced | Q1 2020 24 quarters |
| Lpl Finl HLDGS Inc | 0.2% | 118,294 | 42.3M USD | −43.3% reduced | Q2 2023 11 quarters |
| Toll Brothers Inc | 0.2% | 310,287 | 42.0M USD | −21.3% reduced | Q1 2021 20 quarters |
| PFG Principal Financial Group | 0.2% | 475,487 | 41.9M USD | −3.3% reduced | Q2 2023 11 quarters |
| STT State Street Corporation | 0.2% | 323,786 | 41.8M USD | −28.6% reduced | Q1 2024 8 quarters |
| BNY BNY Mellon | 0.1% | 349,688 | 40.6M USD | −12.7% reduced | Q4 2020 21 quarters |
| TER Teradyne | 0.1% | 199,761 | 38.7M USD | −3.7% reduced | Q3 2025 2 quarters |
| COF Capital One | 0.1% | 157,774 | 38.2M USD | −22.6% reduced | Q2 2024 7 quarters |
| QCOM Qualcomm | 0.1% | 220,092 | 37.6M USD | −58.6% reduced | Q4 2021 17 quarters |
| VRSN Verisign | 0.1% | 152,607 | 37.1M USD | −47.2% reduced | Q2 2024 7 quarters |
| Uipath Inc | 0.1% | 2,224,610 | 36.5M USD | −10.9% reduced | Q1 2024 8 quarters |
| GILD Gilead Sciences | 0.1% | 292,406 | 35.9M USD | −24.1% reduced | Q4 2020 21 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 393 positions.
Breakdown by sector
- Technology 22.3%
- Financials 7.7%
- Consumer Discretionary 5.1%
- Health Care 4.6%
- Industrials 4.2%
- Communication Services 3.9%
- Consumer Staples 1.7%
- Materials 1.0%
- Energy 0.8%
- Utilities 0.8%
- Real Estate 0.2%
- not in our coverage 47.8%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors